CTRI/2010/091/000093已完成2 期
A Phase II/III clinical trial to assess safety and immunogenicity of the Influenza Vaccine (whole virion, Inactivated) A/H1N1 (Pandemic) Administered at two dose levels in Adults, Elderly and Pediatric Populations.
Serum Institute of India Ltd0 个研究点目标入组 330 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 330
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Normal healthy subjects of appropriate age. 2.Free of obvious health problems.
排除标准
- •1.Have a known allergy to eggs or other components of the vaccine.2. pregnancy 3. participating in other clinical trial during the present trial period 4. Altered immune status 5. Acute febrile illness or acute infectious disease. 6. History of a previous severe allergic reaction. 7. History of H1N1 Influenza infection or any influenza vaccination. 8. History of Guillain-Barré Syndrome. 9. Known history of a bleeding disorder contraindicating intramuscular vaccination
研究者
相似试验
已完成
2 期
A multicentric clinical trial of SIIL's H1N1 vaccine (Live) in Adults, Elderly and Children.CTRI/2010/091/000092Serum Institute of India Ltd330
已完成
2 期
A clinical trial to assess safety and immune response of new trivalent Seasonal Influenza vaccine in Adults, Elderly and Pediatric PopulationsCTRI/2012/04/002604Serum Institute of India Ltd290
招募中
不适用
Phase II clinical trial to evaluate the safety and efficacy of particle radiotherapy preceded atezolizumab plus bevacizumab treatment in patients with unresectable multiple hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000048296Kobe University43
进行中（未招募）
1 期
Trial to evaluate the safety and efficacy of a research drug in combination with antiretroviral treatment to cure people infected with HIV-1 without antiretroviral treatment.EUCTR2018-000497-30-ESFundación Pública Andaluza para la Gestión en Salud de Sevilla (FISEVI)12
进行中（未招募）
1 期
Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery.CTIS2024-515235-29-00Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud15